EcoDrugPlus

Ribosomal Protein L28

Ensembl ID : ENSBTAG00000023343
Gene Symbol: RPL28
15 Enzyme and pathways 5 Cross references
230 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSBTAG00000018628
Gene Symbol: RPL29
15 Enzyme and pathways 5 Cross references
352 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSBTAG00000003228
Gene Symbol: RPL3
15 Enzyme and pathways 5 Cross references
264 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSBTAG00000015283
Gene Symbol: RPL32
15 Enzyme and pathways 5 Cross references
243 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSBTAG00000014226
Gene Symbol: RPL34
15 Enzyme and pathways 5 Cross references
180 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSBTAG00000003205
Gene Symbol: RPL35
15 Enzyme and pathways 4 Cross references
239 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSBTAG00000014208
Gene Symbol: RPL35A
15 Enzyme and pathways 5 Cross references
270 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSBTAG00000001794
Gene Symbol: RPL36
15 Enzyme and pathways 4 Cross references
181 Possible Orthologues:

Ribosomal Protein L36a Like

Ensembl ID : ENSBTAG00000025564
Gene Symbol: RPL36AL
15 Enzyme and pathways 4 Cross references
99 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSBTAG00000005142
Gene Symbol: RPL37
15 Enzyme and pathways 4 Cross references
174 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSBTAG00000051254
Gene Symbol: RPL37A
15 Enzyme and pathways 5 Cross references
110 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSBTAG00000030164
Gene Symbol: RPL38
15 Enzyme and pathways 5 Cross references
252 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).